April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc.

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

The harpy eagle is one of the most powerful birds of prey on Earth. With talons reaching up to 9 cm long — larger than a bear ...

A toddler and his family flying home after cancer treatments got a boost of kindness from strangers. An in-flight ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The ...

Massive Bio publishes landmark prospective study demonstrating AI-driven clinical trial matching at scale in 3,804 cancer ...

Iantrek announced controlled early clinical adoption of the AlloSpan Canal at select U.S. sites.The canal-based restoration platform combines a trabecular meshwork-sparing, nitinol-guided canaloplasty ...

Former Agriculture Secretary and Federation of Free Farmers board chairman Leonardo Montemayor and Magsasaka Party-List chairman Argel Joseph Cabatbat ...

Climb Bio on Tuesday said there are currently no FDA-approved treatments for pMN, which affects about 75,000 people in the U.S. and can lead to chronic or end-stage kidney disease, requiring dialysis ...

More than 9,000 Amazon shoppers purchased BYOMA's $17 Bio-Collagen Radiance Mask last month, and the five-star reviews don't ...

AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI ...

Anthropic (ANTHRO) acquires Coefficient Bio for $400M, marking Amazon (AMZN) and Google (GOOG) (GOOGL)-backed firm's latest ...